PDB Short entry for 5KZ7 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-JUL-16 5KZ7 TITLE MARK2 COMPLEX WITH 7-[(1S)-1-(4-FLUOROPHENYL)ETHYL]-5,5-DIMETHYL-2-(3- TITLE 2 PYRIDYLAMINO)PYRROLO[2,3-D]PYRIMIDIN-6-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE MARK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 6-331; COMPND 5 SYNONYM: ELKL MOTIF KINASE 1,EMK-1,MAP/MICROTUBULE AFFINITY- COMPND 6 REGULATING KINASE 2,PAR1 HOMOLOG,PAR1 HOMOLOG B,PAR1B; COMPND 7 EC: 2.7.11.1,2.7.11.26; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MARK2, EMK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MARK, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.P.SU,S.K.MUNSHI REVDAT 2 04-OCT-23 5KZ7 1 REMARK REVDAT 1 31-MAY-17 5KZ7 0 JRNL AUTH J.D.KATZ,A.HAIDLE,K.K.CHILDERS,A.A.ZABIEREK,J.P.JEWELL, JRNL AUTH 2 Y.HOU,M.D.ALTMAN,A.SZEWCZAK,D.CHEN,A.HARSCH,M.HAYASHI, JRNL AUTH 3 L.WARREN,M.HUTTON,H.NUTHALL,H.P.SU,S.MUNSHI,M.G.STANTON, JRNL AUTH 4 I.W.DAVIES,B.MUNOZ,A.NORTHRUP JRNL TITL STRUCTURE GUIDED DESIGN OF A SERIES OF SELECTIVE JRNL TITL 2 PYRROLOPYRIMIDINONE MARK INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 114 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 27816515 JRNL DOI 10.1016/J.BMCL.2016.08.068 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 12561 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 635 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.88 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3095 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2513 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2939 REMARK 3 BIN R VALUE (WORKING SET) : 0.2452 REMARK 3 BIN FREE R VALUE : 0.3652 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.04 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4743 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 94.78 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.46350 REMARK 3 B22 (A**2) : -6.46350 REMARK 3 B33 (A**2) : 12.92690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.615 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.564 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.888 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.803 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4896 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6607 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1728 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 113 ; 8.000 ; HARMONIC REMARK 3 GENERAL PLANES : 692 ; 8.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4896 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 611 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5584 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.21 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.78 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.83 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KZ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1000222944. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12561 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 69.6 REMARK 200 DATA REDUNDANCY : 1.400 REMARK 200 R MERGE (I) : 0.13100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.40 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 5EAK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 14% PEG3350, REMARK 280 200MM AMM.SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.91267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.82533 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.36900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 82.28167 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 16.45633 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 19 REMARK 465 ALA A 20 REMARK 465 HIS A 21 REMARK 465 ASN A 22 REMARK 465 HIS A 23 REMARK 465 ARG A 24 REMARK 465 HIS A 25 REMARK 465 LYS A 26 REMARK 465 HIS A 27 REMARK 465 ALA A 28 REMARK 465 ASP A 29 REMARK 465 TYR A 30 REMARK 465 LYS A 31 REMARK 465 ASP A 32 REMARK 465 ASP A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 35 REMARK 465 LYS A 36 REMARK 465 LYS A 37 REMARK 465 LEU A 38 REMARK 465 ASN A 39 REMARK 465 SER A 40 REMARK 465 ALA A 41 REMARK 465 THR A 42 REMARK 465 SER A 43 REMARK 465 ALA A 44 REMARK 465 ASP A 45 REMARK 465 GLU A 46 REMARK 465 GLN A 47 REMARK 465 PHE A 196 REMARK 465 SER A 197 REMARK 465 ASN A 198 REMARK 465 GLU A 199 REMARK 465 PHE A 200 REMARK 465 THR A 201 REMARK 465 PHE A 202 REMARK 465 GLY A 203 REMARK 465 ASN A 204 REMARK 465 LYS A 205 REMARK 465 LEU A 206 REMARK 465 ASP A 207 REMARK 465 THR A 208 REMARK 465 PHE A 209 REMARK 465 CYS A 210 REMARK 465 GLY A 211 REMARK 465 LYS A 225 REMARK 465 TYR A 226 REMARK 465 GLY A 252 REMARK 465 GLN A 253 REMARK 465 LYS A 364 REMARK 465 MET B 19 REMARK 465 ALA B 20 REMARK 465 HIS B 21 REMARK 465 ASN B 22 REMARK 465 HIS B 23 REMARK 465 ARG B 24 REMARK 465 HIS B 25 REMARK 465 LYS B 26 REMARK 465 HIS B 27 REMARK 465 ALA B 28 REMARK 465 ASP B 29 REMARK 465 TYR B 30 REMARK 465 LYS B 31 REMARK 465 ASP B 32 REMARK 465 ASP B 33 REMARK 465 ASP B 34 REMARK 465 ASP B 35 REMARK 465 LYS B 36 REMARK 465 LYS B 37 REMARK 465 LEU B 38 REMARK 465 ASN B 39 REMARK 465 SER B 40 REMARK 465 ALA B 41 REMARK 465 THR B 42 REMARK 465 SER B 43 REMARK 465 ALA B 44 REMARK 465 ASP B 45 REMARK 465 GLU B 46 REMARK 465 GLN B 47 REMARK 465 PHE B 196 REMARK 465 SER B 197 REMARK 465 ASN B 198 REMARK 465 GLU B 199 REMARK 465 PHE B 200 REMARK 465 THR B 201 REMARK 465 PHE B 202 REMARK 465 GLY B 203 REMARK 465 ASN B 204 REMARK 465 LYS B 205 REMARK 465 LEU B 206 REMARK 465 ASP B 207 REMARK 465 THR B 208 REMARK 465 PHE B 209 REMARK 465 CYS B 210 REMARK 465 GLY B 211 REMARK 465 LYS B 225 REMARK 465 TYR B 226 REMARK 465 GLY B 252 REMARK 465 GLN B 253 REMARK 465 LYS B 364 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 50 CG1 CG2 CD1 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 ASP A 227 CG OD1 OD2 REMARK 470 GLU A 260 CG CD OE1 OE2 REMARK 470 ARG A 264 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 ARG A 327 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 61 CG CD CE NZ REMARK 470 ASN B 63 CG OD1 ND2 REMARK 470 PHE B 194 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 224 CG CD CE NZ REMARK 470 LYS B 266 CG CD CE NZ REMARK 470 SER B 290 OG REMARK 470 LYS B 291 CG CD CE NZ REMARK 470 ARG B 302 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 309 CG CD OE1 OE2 REMARK 470 ASP B 310 CG OD1 OD2 REMARK 470 GLU B 330 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 49 78.12 -158.18 REMARK 500 LEU A 56 -118.19 -109.83 REMARK 500 ASN A 63 91.39 -67.03 REMARK 500 PHE A 64 -24.39 63.97 REMARK 500 ASN A 108 67.92 -155.29 REMARK 500 GLU A 149 -35.35 -38.00 REMARK 500 ARG A 174 -16.36 64.12 REMARK 500 ASP A 175 87.07 -151.08 REMARK 500 ASN A 180 -10.77 -147.05 REMARK 500 ALA A 192 -98.89 -66.59 REMARK 500 GLN A 222 -6.63 -59.52 REMARK 500 LEU A 255 167.37 67.21 REMARK 500 LYS A 256 -48.77 69.60 REMARK 500 HIS A 308 52.70 -141.70 REMARK 500 ASP A 311 74.19 -105.49 REMARK 500 TYR A 316 128.06 -35.61 REMARK 500 GLU A 318 105.92 70.52 REMARK 500 ASP A 322 78.52 -109.45 REMARK 500 HIS B 49 176.47 -58.34 REMARK 500 ILE B 50 -79.70 -166.33 REMARK 500 LEU B 56 -118.47 -109.44 REMARK 500 PHE B 64 2.54 54.26 REMARK 500 ASN B 108 71.19 -154.71 REMARK 500 GLU B 149 -35.95 -36.84 REMARK 500 ARG B 174 2.04 55.60 REMARK 500 ASP B 193 152.42 69.13 REMARK 500 PHE B 194 4.25 -169.56 REMARK 500 PHE B 284 -63.75 -90.12 REMARK 500 HIS B 308 54.52 -150.20 REMARK 500 ASP B 311 74.35 -105.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6Z2 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6Z2 B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5KZ8 RELATED DB: PDB DBREF 5KZ7 A 39 364 UNP Q7KZI7 MARK2_HUMAN 6 331 DBREF 5KZ7 B 39 364 UNP Q7KZI7 MARK2_HUMAN 6 331 SEQADV 5KZ7 MET A 19 UNP Q7KZI7 INITIATING METHIONINE SEQADV 5KZ7 ALA A 20 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS A 21 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASN A 22 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS A 23 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ARG A 24 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS A 25 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS A 26 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS A 27 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ALA A 28 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP A 29 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 TYR A 30 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS A 31 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP A 32 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP A 33 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP A 34 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP A 35 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS A 36 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS A 37 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LEU A 38 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 MET B 19 UNP Q7KZI7 INITIATING METHIONINE SEQADV 5KZ7 ALA B 20 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS B 21 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASN B 22 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS B 23 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ARG B 24 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS B 25 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS B 26 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 HIS B 27 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ALA B 28 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP B 29 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 TYR B 30 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS B 31 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP B 32 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP B 33 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP B 34 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 ASP B 35 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS B 36 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LYS B 37 UNP Q7KZI7 EXPRESSION TAG SEQADV 5KZ7 LEU B 38 UNP Q7KZI7 EXPRESSION TAG SEQRES 1 A 346 MET ALA HIS ASN HIS ARG HIS LYS HIS ALA ASP TYR LYS SEQRES 2 A 346 ASP ASP ASP ASP LYS LYS LEU ASN SER ALA THR SER ALA SEQRES 3 A 346 ASP GLU GLN PRO HIS ILE GLY ASN TYR ARG LEU LEU LYS SEQRES 4 A 346 THR ILE GLY LYS GLY ASN PHE ALA LYS VAL LYS LEU ALA SEQRES 5 A 346 ARG HIS ILE LEU THR GLY LYS GLU VAL ALA VAL LYS ILE SEQRES 6 A 346 ILE ASP LYS THR GLN LEU ASN SER SER SER LEU GLN LYS SEQRES 7 A 346 LEU PHE ARG GLU VAL ARG ILE MET LYS VAL LEU ASN HIS SEQRES 8 A 346 PRO ASN ILE VAL LYS LEU PHE GLU VAL ILE GLU THR GLU SEQRES 9 A 346 LYS THR LEU TYR LEU VAL MET GLU TYR ALA SER GLY GLY SEQRES 10 A 346 GLU VAL PHE ASP TYR LEU VAL ALA HIS GLY ARG MET LYS SEQRES 11 A 346 GLU LYS GLU ALA ARG ALA LYS PHE ARG GLN ILE VAL SER SEQRES 12 A 346 ALA VAL GLN TYR CYS HIS GLN LYS PHE ILE VAL HIS ARG SEQRES 13 A 346 ASP LEU LYS ALA GLU ASN LEU LEU LEU ASP ALA ASP MET SEQRES 14 A 346 ASN ILE LYS ILE ALA ASP PHE GLY PHE SER ASN GLU PHE SEQRES 15 A 346 THR PHE GLY ASN LYS LEU ASP THR PHE CYS GLY SER PRO SEQRES 16 A 346 PRO TYR ALA ALA PRO GLU LEU PHE GLN GLY LYS LYS TYR SEQRES 17 A 346 ASP GLY PRO GLU VAL ASP VAL TRP SER LEU GLY VAL ILE SEQRES 18 A 346 LEU TYR THR LEU VAL SER GLY SER LEU PRO PHE ASP GLY SEQRES 19 A 346 GLN ASN LEU LYS GLU LEU ARG GLU ARG VAL LEU ARG GLY SEQRES 20 A 346 LYS TYR ARG ILE PRO PHE TYR MET SER THR ASP CYS GLU SEQRES 21 A 346 ASN LEU LEU LYS LYS PHE LEU ILE LEU ASN PRO SER LYS SEQRES 22 A 346 ARG GLY THR LEU GLU GLN ILE MET LYS ASP ARG TRP MET SEQRES 23 A 346 ASN VAL GLY HIS GLU ASP ASP GLU LEU LYS PRO TYR VAL SEQRES 24 A 346 GLU PRO LEU PRO ASP TYR LYS ASP PRO ARG ARG THR GLU SEQRES 25 A 346 LEU MET VAL SER MET GLY TYR THR ARG GLU GLU ILE GLN SEQRES 26 A 346 ASP SER LEU VAL GLY GLN ARG TYR ASN GLU VAL MET ALA SEQRES 27 A 346 THR TYR LEU LEU LEU GLY TYR LYS SEQRES 1 B 346 MET ALA HIS ASN HIS ARG HIS LYS HIS ALA ASP TYR LYS SEQRES 2 B 346 ASP ASP ASP ASP LYS LYS LEU ASN SER ALA THR SER ALA SEQRES 3 B 346 ASP GLU GLN PRO HIS ILE GLY ASN TYR ARG LEU LEU LYS SEQRES 4 B 346 THR ILE GLY LYS GLY ASN PHE ALA LYS VAL LYS LEU ALA SEQRES 5 B 346 ARG HIS ILE LEU THR GLY LYS GLU VAL ALA VAL LYS ILE SEQRES 6 B 346 ILE ASP LYS THR GLN LEU ASN SER SER SER LEU GLN LYS SEQRES 7 B 346 LEU PHE ARG GLU VAL ARG ILE MET LYS VAL LEU ASN HIS SEQRES 8 B 346 PRO ASN ILE VAL LYS LEU PHE GLU VAL ILE GLU THR GLU SEQRES 9 B 346 LYS THR LEU TYR LEU VAL MET GLU TYR ALA SER GLY GLY SEQRES 10 B 346 GLU VAL PHE ASP TYR LEU VAL ALA HIS GLY ARG MET LYS SEQRES 11 B 346 GLU LYS GLU ALA ARG ALA LYS PHE ARG GLN ILE VAL SER SEQRES 12 B 346 ALA VAL GLN TYR CYS HIS GLN LYS PHE ILE VAL HIS ARG SEQRES 13 B 346 ASP LEU LYS ALA GLU ASN LEU LEU LEU ASP ALA ASP MET SEQRES 14 B 346 ASN ILE LYS ILE ALA ASP PHE GLY PHE SER ASN GLU PHE SEQRES 15 B 346 THR PHE GLY ASN LYS LEU ASP THR PHE CYS GLY SER PRO SEQRES 16 B 346 PRO TYR ALA ALA PRO GLU LEU PHE GLN GLY LYS LYS TYR SEQRES 17 B 346 ASP GLY PRO GLU VAL ASP VAL TRP SER LEU GLY VAL ILE SEQRES 18 B 346 LEU TYR THR LEU VAL SER GLY SER LEU PRO PHE ASP GLY SEQRES 19 B 346 GLN ASN LEU LYS GLU LEU ARG GLU ARG VAL LEU ARG GLY SEQRES 20 B 346 LYS TYR ARG ILE PRO PHE TYR MET SER THR ASP CYS GLU SEQRES 21 B 346 ASN LEU LEU LYS LYS PHE LEU ILE LEU ASN PRO SER LYS SEQRES 22 B 346 ARG GLY THR LEU GLU GLN ILE MET LYS ASP ARG TRP MET SEQRES 23 B 346 ASN VAL GLY HIS GLU ASP ASP GLU LEU LYS PRO TYR VAL SEQRES 24 B 346 GLU PRO LEU PRO ASP TYR LYS ASP PRO ARG ARG THR GLU SEQRES 25 B 346 LEU MET VAL SER MET GLY TYR THR ARG GLU GLU ILE GLN SEQRES 26 B 346 ASP SER LEU VAL GLY GLN ARG TYR ASN GLU VAL MET ALA SEQRES 27 B 346 THR TYR LEU LEU LEU GLY TYR LYS HET 6Z2 A 401 28 HET 6Z2 B 401 28 HETNAM 6Z2 7-[(1~{S})-1-(4-FLUOROPHENYL)ETHYL]-5,5-DIMETHYL-2- HETNAM 2 6Z2 (PYRIDIN-3-YLAMINO)PYRROLO[2,3-D]PYRIMIDIN-6-ONE FORMUL 3 6Z2 2(C21 H20 F N5 O) HELIX 1 AA1 ASN A 90 LEU A 107 1 18 HELIX 2 AA2 VAL A 137 HIS A 144 1 8 HELIX 3 AA3 LYS A 148 LYS A 169 1 22 HELIX 4 AA4 SER A 212 ALA A 216 5 5 HELIX 5 AA5 ALA A 217 PHE A 221 5 5 HELIX 6 AA6 GLY A 228 GLY A 246 1 19 HELIX 7 AA7 LYS A 256 GLY A 265 1 10 HELIX 8 AA8 SER A 274 LEU A 285 1 12 HELIX 9 AA9 THR A 294 MET A 299 1 6 HELIX 10 AB1 LYS A 300 ASP A 301 5 2 HELIX 11 AB2 ARG A 302 VAL A 306 5 5 HELIX 12 AB3 ASP A 325 MET A 335 1 11 HELIX 13 AB4 THR A 338 GLY A 348 1 11 HELIX 14 AB5 ASN A 352 GLY A 362 1 11 HELIX 15 AB6 THR B 87 LEU B 89 5 3 HELIX 16 AB7 ASN B 90 LEU B 107 1 18 HELIX 17 AB8 VAL B 137 HIS B 144 1 8 HELIX 18 AB9 LYS B 148 LYS B 169 1 22 HELIX 19 AC1 SER B 212 ALA B 216 5 5 HELIX 20 AC2 GLY B 228 GLY B 246 1 19 HELIX 21 AC3 LEU B 255 GLY B 265 1 11 HELIX 22 AC4 SER B 274 LEU B 285 1 12 HELIX 23 AC5 ASN B 288 ARG B 292 5 5 HELIX 24 AC6 THR B 294 LYS B 300 1 7 HELIX 25 AC7 ASP B 301 VAL B 306 5 6 HELIX 26 AC8 ASP B 325 MET B 335 1 11 HELIX 27 AC9 THR B 338 GLY B 348 1 11 HELIX 28 AD1 ASN B 352 GLY B 362 1 11 SHEET 1 AA1 5 TYR A 53 LEU A 55 0 SHEET 2 AA1 5 ALA A 65 HIS A 72 -1 O ARG A 71 N ARG A 54 SHEET 3 AA1 5 GLU A 78 ASP A 85 -1 O VAL A 79 N ALA A 70 SHEET 4 AA1 5 THR A 124 GLU A 130 -1 O LEU A 125 N ILE A 84 SHEET 5 AA1 5 LEU A 115 GLU A 120 -1 N PHE A 116 O VAL A 128 SHEET 1 AA2 3 GLY A 135 GLU A 136 0 SHEET 2 AA2 3 LEU A 181 LEU A 183 -1 O LEU A 183 N GLY A 135 SHEET 3 AA2 3 ILE A 189 ILE A 191 -1 O LYS A 190 N LEU A 182 SHEET 1 AA3 5 TYR B 53 LEU B 55 0 SHEET 2 AA3 5 ALA B 65 HIS B 72 -1 O ARG B 71 N ARG B 54 SHEET 3 AA3 5 GLU B 78 ASP B 85 -1 O ILE B 83 N LYS B 66 SHEET 4 AA3 5 THR B 124 GLU B 130 -1 O LEU B 127 N LYS B 82 SHEET 5 AA3 5 LEU B 115 GLU B 120 -1 N PHE B 116 O VAL B 128 SHEET 1 AA4 3 GLY B 135 GLU B 136 0 SHEET 2 AA4 3 LEU B 182 LEU B 183 -1 O LEU B 183 N GLY B 135 SHEET 3 AA4 3 ILE B 189 LYS B 190 -1 O LYS B 190 N LEU B 182 SITE 1 AC1 11 ILE A 59 VAL A 67 ALA A 80 LYS A 82 SITE 2 AC1 11 GLU A 130 TYR A 131 ALA A 132 GLY A 135 SITE 3 AC1 11 GLU A 136 LEU A 182 ASP A 193 SITE 1 AC2 11 ILE B 59 VAL B 67 ALA B 80 LYS B 82 SITE 2 AC2 11 GLU B 130 TYR B 131 ALA B 132 GLU B 136 SITE 3 AC2 11 GLU B 179 ASN B 180 LEU B 182 CRYST1 119.350 119.350 98.738 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008379 0.004837 0.000000 0.00000 SCALE2 0.000000 0.009675 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010128 0.00000